Retrospective Study
Copyright ©The Author(s) 2025.
World J Clin Pediatr. Jun 9, 2025; 14(2): 102049
Published online Jun 9, 2025. doi: 10.5409/wjcp.v14.i2.102049
Table 1 Demographic and clinical characteristics of the study participants, n (%)
Variables
Total (n = 289)
Restricted parental care (n = 167)
Unrestricted parental care (n = 122)
P value
Age (years), median (IQR)5.6 (2.0-12.8)7.5 (2.8-13.7)3.5 (1.3-10.8)< 0.01
Sex, male134 (46.4)69 (41.3)65 (53.3)0.04
Weight (kg), median (IQR)17.4 (11-32.4)19.6 (12-39)15 (9.5-28.8)< 0.01
Comorbidities, yes37 (12.8)26 (15.)11 (9.0)0.10
Presence of cerebral palsy, yes13 (4.5)11 (6.7)2 (1.6)0.05
Type of surgery
Orthopedic134 (46.4)90 (53.9)44 (36.1)< 0.01
Abdominal91 (31.5)47 (28.1)44 (36.1)-
Other64 (22.1)30 (18.0)34 (27.8)-
LOS in ICU (days), median (IQR)2 (2-3)2 (2-3)2 (2-4)0.04
Hospital LOS, mean ± SD16.0 ± 6.514.6 ± 6.018.2 ± 6.5< 0.001
RASS, mean ± SD1.1 ± 0.31.2 ± 0.51.0 ± 0.2< 0.01
Received diazepam56 (19.4)45 (27.0)11 (9.0)< 0.001
Diazepam dose (mg/kg), median (IQR)0.1 (0.1-0.1)0.1 (0.1-0.1)0.1 (0.1-0.1)0.74
Received dexmedetomidine3 (1.0)1 (0.6)2 (1.6)0.58
Dexmedetomidine dose (mg/kg), median (IQR)0.7 (0.7-0.7)0.7 (0.7-0.7)0.7 (0.7-0.7)1.00
Received trimeperidine209 (72.3)133 (79.6)76 (62.3)< 0.01
Trimeperidine dose (mg/kg), median (IQR)0.2 (0.15-0.25)0.2 (0.2-0.25)0.2 (0.15-0.25)1.00
Received morphine86 (29.8)35 (21.0)51 (41.8)< 0.001
Morphine dose (mg/kg), median (IQR)0.1 (0.1-0.1)0.1 (0.1-0.1)0.1 (0.1-0.1)0.81